Holen Sie sich die Stockscreener-App
2.505
5.47%
-0.145
Schlusskurs vom Vortag:
$2.65
Offen:
$2.7
24-Stunden-Volumen:
638.66K
Relative Volume:
0.89
Marktkapitalisierung:
$216.97M
Einnahmen:
$405.47M
Nettoeinkommen (Verlust:
$53.66M
KGV:
3.4792
EPS:
0.72
Netto-Cashflow:
$131.28M
1W Leistung:
-10.22%
1M Leistung:
-16.50%
6M Leistung:
-37.22%
1J Leistung:
-54.04%
1-Tages-Spanne:
$2.50
$2.7299
1-Wochen-Bereich:
$2.42
$2.76
52-Wochen-Spanne:
$2.42
$5.55
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Vergleichen Sie OSUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.505 | 216.97M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
563.12 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
87.80 | 47.48B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
171.49 | 47.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
247.25 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
79.67 | 16.11B | 3.93B | 415.40M | 384.70M | 2.06 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
OraSure in pact for celiac disease testing (OSUR:NASDAQ) - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac Testing | OSUR Stock News - GuruFocus
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com Canada
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Announces First Quarter 2025 Financial Results - The Manila Times
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies: Historically Cheap (NASDAQ:OSUR) - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th - The Manila Times
OraSure Technologies, Inc. Schedules Q1 2025 Earnings Conference Call for May 7, 2025 - Nasdaq
OraSure Q1 2025 Earnings Preview: Key Financial Metrics and Live Q&A Session Coming May 7 - Stock Titan
Your Guide to Rapid Testing for Syphilis, HIV & HCV - Labroots
OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference - marketscreener.com
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? - Nasdaq
Premier Biotech Increases Offerings and Global Distribution Network with Recent Acquisitions - The Joplin Globe
Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™ - The Globe and Mail
OraSure Technologies (NASDAQ:OSUR shareholders incur further losses as stock declines 12% this week, taking five-year losses to 75% - Yahoo Finance
Insider Stock Buying Reaches US$761.0k On OraSure Technologies - simplywall.st
OraSure Technologies Elects Jack Kenny to the Board of Directors - marketscreener.com
OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 - Insider Monkey
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
OraSure announces $40M stock buy back - Lehigh Valley Business
OraSure announces $40 million stock buyback plan By Investing.com - Investing.com Australia
OraSure announces $40 million stock repurchase program - WFMZ.com
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orasure Technologies Inc-Aktie (OSUR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
| Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
| McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
| Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):